Secondary Outcomes
SECONDARY
The evaluation of the secondary outcomes was conducted for the PP population. The mean (SD) number of medications taken in the control group at T0 was 9.24 (3.44) per patient and 9.32 (3.59) at T1. In comparison, participants in the intervention group were taking a mean (SD) of 8.98 (3.56) medicines at T0. The number of medicines per patient decreased to 8.11 (3.21) at T1 and remained almost constant at 8.49 (3.63) at T2. At T1, a statistically significant difference between the groups was demonstrated (incidence rate ratio [IRR], 0.88; 